MB "Rio pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2023 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
0 |
0 |
0 |
0 |
2024 |
---|
2 |
- |
-88 |
-88 |
- |
100.00 |
-4,400.00 |
912 |
48 |
0 |
960 |
Register and
explore Okredo data2024 |
---|
2 |
- |
-88 |
-88 |
- |
100.00 |
-4,400.00 |
912 |
48 |
0 |
960 |
Register and
explore Okredo data2024
Turnover (€)
2 €- *
Sales per employee (€)
-Profit before tax (€)
-88 €- *
Net Profit (€)
-88 €- *
Profit per employee (€)
-Total profitability (%)
100.00 %- *
Net profitability (%)
-4,400.00 %- *
Equity (€)
912 €- *
Amounts Payable And Liabilities (€)
48 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
960 €- *